STE

MKT CAP:$22B

STERIS plc

Market Cap

$22B

Healthcare·Medical - Devices·🇮🇪 Ireland·NYSE

Healthcare·Medical - Devices·🇮🇪·NYSE

Stock Price

$222.60-$27.44 (-10.97%)

Apr 21, 2026

Company Details

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers clean...

CEO

Daniel A. Carestio

IPO Date

Jun 1, 1992

Website

www.steris.com

Key Metrics TTM

Revenue

$5.7B

+10.8% YoY

Net Income

$689M

EPS (Diluted)

$6.96

Free Cash Flow

$961M

Revenue / Share

$57.72

Gross Margin

44.3%

Operating Margin

17.1%

Net Margin

12.1%

FCF Margin

16.9%

P/S

3.8x

P/E

31.8x

Earnings Reports

Q3 2026

May 13, 2026

PENDING

Q2 2026

Nov 6, 2025

$1.5BEPS $1.94

Q1 2026

Aug 7, 2025

$1.4B+8.7%EPS $1.79

FY 2025

May 29, 2025

$5.5B+6.2%EPS $6.20

Q4 2025

May 29, 2025

$1.5BEPS $1.48

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$809M	$346M	$147M
Q1 22	$968M	$426M	$14M
Q2 22	$1.2B	$480M	$117M
Q3 22	$1.2B	$538M	$203M
Q4 22	$1.2B	$572M	$92M
Q1 23	$1.2B	$518M	$158M
Q2 23	$1.2B	$532M	-$306M
Q3 23	$1.2B	$521M	$191M
Q4 23	$1.4B	$588M	$225M
Q1 24	$1.2B	$529M	$198M
Q3 24	$1.3B	$560M	$226M
Q1 25	$1.3B	$572M	$186M
Q3 25	$1.4B	$610M	$245M
Q4 25	$1.5B	$641M	$216M
Q1 26	$1.4B	$628M	$246M
Q2 26	$1.5B	$646M	$268M

Valuation

Quarter	P/S	P/E
Q3 21	6.9x	48.8x
Q1 22	6.5x	68.1x
Q2 22	5.9x	81.6x
Q3 22	5.2x	71.6x
Q4 22	4.8x	89.8x
Q1 23	4.6x	58.1x
Q2 23	4.6x	—
Q3 23	4.6x	—
Q4 23	4.4x	204.7x
Q1 24	4.4x	183.6x
Q3 24	4.3x	38.1x
Q1 25	4.3x	36.7x
Q3 25	4.3x	37.6x
Q4 25	4.0x	36.2x
Q1 26	4.0x	34.1x
Q2 26	3.8x	31.8x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	$206M	$152M
Q1 22	$97M	$41M
Q2 22	$171M	$94M
Q3 22	$244M	$163M
Q4 22	$172M	$99M
Q1 23	$232M	$116M
Q2 23	$104M	$21M
Q3 23	$206M	$114M
Q4 23	$216M	$144M
Q1 24	$281M	$215M
Q3 24	$291M	$172M
Q1 25	$304M	$196M
Q3 25	$333M	$244M
Q4 25	$261M	$190M
Q1 26	$420M	$326M
Q2 26	$288M	$201M

Capital Expenditures

Quarter	CapEx
Q3 21	$54M
Q1 22	$56M
Q2 22	$77M
Q3 22	$81M
Q4 22	$73M
Q1 23	$116M
Q2 23	$83M
Q3 23	$92M
Q4 23	$71M
Q1 24	$67M
Q3 24	$119M
Q1 25	$108M
Q3 25	$89M
Q4 25	$71M
Q1 26	$94M
Q2 26	$87M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	+9.8%	+8.5%
Q1 22	+25.1%	+51.0%
Q2 22	+45.4%	+62.4%
Q3 22	+59.9%	+63.6%
Q4 22	+49.7%	+69.0%
Q1 23	+19.4%	+4.6%
Q2 23	+0.3%	+39.5%
Q3 23	+0.6%	+1.9%
Q4 23	+14.4%	+3.6%
Q1 24	+2.3%	-1.2%
Q3 24	+8.1%	-28.9%
Q1 25	+5.2%	+6.7%
Q3 25	-1.0%	-2.9%
Q4 25	+25.1%	+28.3%
Q1 26	+7.2%	+6.9%
Q2 26	+14.1%	+9.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$6M	0.7%
Q1 22	$27M	2.7%
Q2 22	$11M	0.9%
Q3 22	$10M	0.8%
Q4 22	$10M	0.8%
Q1 23	$9M	0.8%
Q2 23	$12M	1.0%
Q3 23	$9M	0.8%
Q4 23	$9M	0.7%
Q1 24	$12M	1.0%
Q3 24	$15M	1.2%
Q1 25	$12M	0.9%
Q3 25	$15M	1.1%
Q4 25	$10M	0.7%
Q1 26	$12M	0.9%
Q2 26	$21M	1.5%

OpEx Breakdown

Quarter	R&D	SG&A
Q3 21	$16M	$182M
Q1 22	$18M	$394M
Q2 22	$19M	$345M
Q3 22	$25M	$311M
Q4 22	$26M	$454M
Q1 23	$25M	$335M
Q2 23	$25M	$323M
Q3 23	$26M	$305M
Q4 23	$26M	$336M
Q1 24	$25M	$307M
Q3 24	$25M	$308M
Q1 25	$26M	$336M
Q3 25	$27M	$335M
Q4 25	$28M	$334M
Q1 26	$26M	$354M
Q2 26	$28M	$350M

Revenue Segments

Quarter	Product	Service
Q3 21	$375M	$434M
Q1 22	$489M	$479M
Q2 22	$685M	$512M
Q3 22	$697M	$512M
Q4 22	$685M	$526M
Q1 23	$637M	$519M
Q2 23	$666M	$534M
Q3 23	$679M	$537M
Q4 23	$803M	$582M
Q1 25	$656M	$623M
Q3 25	$718M	$652M
Q4 25	$801M	$679M
Q1 26	$691M	$701M
Q2 26	$745M	$715M

Revenue by Geography

Quarter	Ireland	Other foreign locations	United States
Q3 21	$20M	$216M	$572M
Q1 22	$22M	$267M	$679M
Q2 22	$20M	$324M	$852M
Q3 22	$20M	$338M	$851M
Q4 22	$20M	$345M	$846M
Q1 23	$18M	$304M	$834M
Q2 23	$17M	$312M	$872M
Q3 23	$18M	$315M	$883M
Q4 23	$21M	$366M	$997M
Q1 25	$22M	$310M	$947M
Q3 25	$24M	$344M	$1.0B
Q4 25	$38M	$364M	$1.1B
Q1 26	$23M	$343M	$1.0B
Q2 26	$27M	$358M	$1.1B

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$348M	$0	$348M
Q1 23	$316M	$0	$316M
Q2 23	$258M	$0	$258M
Q3 23	$259M	$0	$259M
Q4 23	$208M	$0	$208M
Q1 24	$209M	$0	$209M
Q2 24	$214M	$0	$214M
Q3 24	$196M	$0	$196M
Q4 24	$207M	$0	$207M
Q1 25	$198M	$0	$198M
Q2 25	$172M	$0	$172M
Q3 25	$155M	$0	$155M
Q4 25	$172M	$0	$172M
Q1 26	$280M	$0	$280M
Q2 26	$319M	$0	$319M
Q3 26	$424M	$0	$424M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	86M	+0.2%	+0.4%
Q1 22	91M	+5.8%	+6.3%
Q2 22	101M	+10.7%	+17.5%
Q3 22	101M	+0.1%	+17.5%
Q4 22	101M	-0.0%	+17.2%
Q1 23	101M	-0.1%	+10.7%
Q2 23	100M	-0.7%	-0.7%
Q3 23	100M	+0.2%	-0.7%
Q4 23	100M	-0.6%	-1.2%
Q1 24	99M	-0.3%	-1.5%
Q3 24	99M	+0.1%	-0.6%
Q1 25	99M	+0.0%	-0.8%
Q3 25	99M	-0.4%	-0.6%
Q4 25	99M	-0.2%	-0.5%
Q1 26	99M	+0.0%	-0.6%
Q2 26	99M	0.0%	-0.6%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$62.2K	13K
Q1 22	$74.5K	13K
Q2 22	$92.1K	13K
Q3 22	$93.0K	13K
Q4 22	$75.7K	16K
Q1 23	$72.3K	16K
Q2 23	$75.0K	16K
Q3 23	$76.0K	16K
Q4 23	$81.5K	17K
Q1 24	$69.6K	17K
Q3 24	$76.3K	17K
Q1 25	$345.8K	4K
Q3 25	$370.4K	4K
Q4 25	$82.3K	18K
Q1 26	$77.3K	18K
Q2 26	$81.1K	18K

Revenue / Employee